Hansa Biopharma AB (publ) (HNSBF) Short Interest Ratio & Short Volume → Mysterious Gold Leverage Just Announced (From Stansberry Research) (Ad) Free HNSBF Stock Alerts $2.93 0.00 (0.00%) (As of 04/24/2024 ET) Add Compare Share Share Short InterestStock AnalysisChartHeadlinesShort InterestStock AnalysisChartHeadlinesShort Interest Hansa Biopharma AB (publ) Short Interest DataCurrent Short Volume590,200 sharesPrevious Short Volume586,300 sharesChange Vs. Previous Month+0.67%Dollar Volume Sold Short$1.73 millionShort Interest Ratio / Days to Cover0.0Last Record DateApril 15, 2024Today's Trading Volume0 sharesAverage Trading Volume425 sharesToday's Volume Vs. Average0% Short Selling Hansa Biopharma AB (publ) ? Sign up to receive the latest short interest report for Hansa Biopharma AB (publ) and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatHNSBF Short Interest Over TimeHNSBF Days to Cover Over TimeHNSBF Percentage of Float Shorted Over Time Ad Stansberry ResearchMysterious Gold Leverage Just AnnouncedWorld's biggest multibillionaire investor group is buying THIS by the tons Most folks have completely missed the fact that there's one group of investors so powerful they're literally buying ONE THING by the tons… Stacking it in their locked vaults on pallets in record numbers.Find out what it is and see how you can get in with just a few dollars. Hansa Biopharma AB (publ) Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/2024590,200 shares $1.73 million +0.7%N/A0 $2.93 3/31/2024586,300 shares $1.72 million -1.8%N/A0 $2.93 3/15/2024596,900 shares $1.94 million +4.4%N/A746.1 $3.26 2/29/2024571,500 shares $1.86 million -0.2%N/A0 $3.26 2/15/2024572,600 shares $1.86 million +7.7%N/A2863 $3.26 1/15/2024451,800 shares $1.20 million -0.6%N/A4518 $2.65 Get the Latest News and Ratings for HNSBF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Hansa Biopharma AB (publ) and its competitors with MarketBeat's FREE daily newsletter. 12/31/2023454,600 shares $1.03 million -0.4%N/A235.2 $2.26 12/15/2023456,200 shares $1.37 million -0.2%N/A0 $3.00 11/30/2023457,000 shares $1.37 million +3.0%N/A0 $3.00 11/15/2023443,500 shares $1.33 million -2.4%N/A0 $3.00 10/31/2023454,500 shares $1.36 million -15.7%N/A0 $3.00 10/15/2023538,800 shares $1.62 million -0.2%N/A5388 $3.00 9/30/2023539,800 shares $2.12 million -0.5%N/A0 $3.93 9/15/2023542,500 shares $2.13 million No ChangeN/A5425 $3.93 8/31/2023542,500 shares $2.13 million +0.4%N/A1629 $3.93 8/15/2023540,200 shares $2.57 million +0.4%N/A0 $4.76 7/31/2023538,300 shares $2.85 million +1.6%N/A2691.5 $5.30 7/15/2023530,100 shares $2.81 million +3.2%N/A0 $5.30 6/30/2023513,600 shares $2.72 million -0.1%N/A0 $5.30 6/15/2023514,200 shares $2.72 million -0.1%N/A0 $5.30 5/31/2023514,700 shares $2.73 million -0.4%N/A0 $5.30 5/15/2023517,000 shares $2.74 million -0.4%N/A574.4 $5.30 4/30/2023519,100 shares $2.70 million +0.2%N/A0 $5.20 4/15/2023517,900 shares $2.69 million -0.3%N/A0 $5.20 3/31/2023519,200 shares $2.70 million +3.3%N/A0 $5.20 3/15/2023502,600 shares $2.61 million -11.4%N/A5026 $5.20 2/28/2023567,000 shares $2.95 million +2.8%N/A0 $5.20 2/15/2023551,600 shares $2.87 million +16.0%N/A2758 $5.20 1/31/2023475,700 shares $3.14 million -0.9%N/A528.6 $6.60 1/15/2023480,000 shares $2.40 million +9.5%N/A1600 $5.01 12/30/2022438,400 shares $2.16 million -8.8%N/A0 $4.93 12/15/2022480,700 shares $2.37 million +2.0%N/A4807 $4.93 11/30/2022471,200 shares $2.27 million +2.7%N/A0 $4.82 11/15/2022458,700 shares $2.21 million +6.5%N/A655.3 $4.82 10/31/2022430,800 shares $2.48 million +0.5%N/A0 $5.75 10/15/2022428,500 shares $2.46 million -10.8%N/A0 $5.75 9/30/2022480,200 shares $2.76 million +7.9%N/A0 $5.75 9/15/2022445,000 shares $2.56 million +20.5%N/A4450 $5.75 8/31/2022369,400 shares $2.09 million +12.0%N/A284.2 $5.66 8/15/2022329,800 shares $1.87 million -22.2%N/A0 $5.66Mysterious Gold Leverage Just Announced (Ad)World's biggest multibillionaire investor group is buying THIS by the tons Most folks have completely missed the fact that there's one group of investors so powerful they're literally buying ONE THING by the tons… Stacking it in their locked vaults on pallets in record numbers.Find out what it is and see how you can get in with just a few dollars. HNSBF Short Interest - Frequently Asked Questions What is Hansa Biopharma AB (publ)'s current short interest? Short interest is the volume of Hansa Biopharma AB (publ) shares that have been sold short but have not yet been covered or closed out. As of April 15th, investors have sold 590,200 shares of HNSBF short. Learn More on Hansa Biopharma AB (publ)'s current short interest. Is Hansa Biopharma AB (publ)'s short interest increasing or decreasing? Hansa Biopharma AB (publ) saw a increase in short interest in April. As of April 15th, there was short interest totaling 590,200 shares, an increase of 0.7% from the previous total of 586,300 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Hansa Biopharma AB (publ) stock? Short selling HNSBF is an investing strategy that aims to generate trading profit from Hansa Biopharma AB (publ) as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Hansa Biopharma AB (publ)? A short squeeze for Hansa Biopharma AB (publ) occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of HNSBF, which in turn drives the price of the stock up even further. How often is Hansa Biopharma AB (publ)'s short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including HNSBF, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: 180 Life Sciences Short Interest Data 3SBio Short Interest Data Abcam Short Interest Data Algernon Pharmaceuticals Short Interest Data Alpha Tau Medical Short Interest Data Apollomics Short Interest Data Artelo Biosciences Short Interest Data Ascentage Pharma Group International Short Interest Data Ascletis Pharma Short Interest Data Avacta Group Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:HNSBF) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap Profitstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyThe only accurate crypto trading system I know …Weiss RatingsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Press